No definition available.
Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
C3_OROPHARYNG_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
169 |
4. Check minimum number of eventsNone |
169 |
5. Include endpointsNone |
169 |
6. Filter based on genotype QC (FinnGen only) |
169 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 169 | 56 | 113 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 64.23 | 61.26 | 65.70 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 50
- Matched controls
- 498
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
47.8
38
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
388.8
34.5
31
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
710.7
34.3
30
*
WF002
NOMESCO Finland
Radical radiotherapy
563.2
30.2
27
*
A03FA01
ATC
metoclopramide; systemic, rectal
36.6
24.7
34
27
N02AA05
ATC
oxycodone; systemic
33.4
23.5
33
27
R4190
NOMESCO Finland
Nutritional therapy
68.7
22.6
25
7
8070/3-C10.9
ICD-O-3
Squamous cell carcinoma, NOS, of oropharynx, NOS
+∞
21.4
19
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.4
19
*
C10.3
ICD-10 Finland
Malignant neoplasm: Posterior wall of oropharynx
+∞
18.9
17
*
H02AB02
ATC
dexamethasone; systemic
250.2
17.7
17
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
16.6
15
*
UJC01
NOMESCO Finland
Scopy of lower throat
+∞
16.6
15
*
A04AA01
ATC
ondansetron; systemic, rectal
54.5
15.7
18
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
15.4
14
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
14.2
13
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
14.2
13
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
24.9
12.3
17
10
C10.0
ICD-10 Finland
Malignant neoplasm: Vallecula
+∞
10.8
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
8.2
10.7
31
83
XX3DW
NOMESCO Finland
Time consuming IT work
23.0
10.7
15
9
EBA15
NOMESCO Finland
Extraction of large number of teeth
27.0
10.5
14
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
34.2
10.4
13
5
C10.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oropharynx
+∞
9.7
9
*
GBB00
NOMESCO Finland
Tracheostomy
30.8
9.4
12
5
SAA03
NOMESCO Finland
Extended examination of mouth
6.4
8.8
34
124
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
18.9
8.8
13
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
107.4
8.7
9
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.6
8
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
8.6
8
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
8.6
8
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
8.6
8
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
30.5
7.9
10
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
93.4
7.6
8
*
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
7.5
7
*
C10.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of oropharynx
+∞
7.5
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.5
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.5
7
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
+∞
7.5
7
*
R4110
NOMESCO Finland
Physiotherapy
5.6
7.1
25
76
A02BC05
ATC
esomeprazole; systemic
5.2
7.0
34
144
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
8.8
7.0
15
23
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
26.8
6.9
9
*
WX402
NOMESCO Finland
General anaesthesia
6.6
6.7
18
39
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
8.8
6.6
14
21
Z51.5
ICD-10 Finland
Palliative care
21.4
6.5
9
5
WW500
NOMESCO Finland
Blood transfusion
31.0
6.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
12.4
6.4
11
11
8070/3-C10.3
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of oropharynx
+∞
6.4
6
*
A06AD11
ATC
lactulose; oral
6.2
6.1
17
38
R13
ICD-10 Finland
Dysphagia
13.5
6.1
10
9
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
21
12
19.84
25.96
1.1
1.2
—
—
—
0
0
103
555
3.19
12.22
6.0
3.5
—
—
—
0
0
115
683
3.14
11.10
14.4
6.3
4.6
4.4
e9/l
0.43
103
604
11
11
10.63
9.64
1.5
1.3
—
—
—
0
0
28
77
4.16
9.46
1.7
1.4
—
—
—
0
0
11
12
9.74
9.08
1.5
1.2
—
—
—
0
0
60
279
2.78
8.69
3.1
2.0
—
—
—
0
0
11
14
8.33
8.08
1.7
1.2
—
—
—
0
0
11
15
7.77
7.64
1.1
1.1
—
—
—
0
0
45
191
2.85
7.63
2.2
1.7
—
—
—
0
0
98
618
2.39
7.11
13.8
5.7
1.2
1.2
mmol/l
0.56
87
533
34
129
3.05
7.01
1.9
1.7
—
—
—
0
0
12
20
6.38
7.00
1.7
1.2
—
—
—
0
0
33
131
2.89
6.25
2.1
1.6
—
—
—
0
0
11
19
6.12
6.19
1.7
1.2
—
—
—
0
0
10
16
6.58
6.02
1.0
1.0
—
—
—
0
0
16
41
4.21
5.86
3.3
3.9
—
—
—
0
0
28
106
2.97
5.75
4.2
2.1
76.6
60.2
ml/min/173m2
1.47
12
45
86
567
2.05
5.00
11.6
5.2
1.2
1.2
mmol/l
0.27
81
505
11
24
4.83
4.85
1.7
1.3
—
—
—
0
0
8
7
11.91
4.83
1.5
1.4
—
—
—
0
0
110
808
2.04
4.58
9.4
4.4
6.7
6.9
mmol/l
0.57
110
756
9
12
7.85
4.41
1.9
1.1
—
—
—
0
0
34
171
2.24
3.89
14.7
6.6
5.4
5.2
kpa
0.84
34
163
34
171
2.24
3.89
14.7
6.5
13.3
11.5
kpa
1.49
34
165
34
172
2.22
3.83
14.6
6.6
1.5
1.6
mmol/l
0.08
29
136
40
220
2.07
3.65
1.8
1.8
30.5
29.8
s
0.28
40
213
26
125
2.28
3.29
15.8
5.8
1.1
1.4
mmol/l
1.50
26
118
8
15
5.54
3.23
1.9
1.1
—
—
—
0
0
6
8
7.72
3.08
2.0
1.1
—
—
—
0
0
7
12
6.03
3.05
2.0
1.1
—
—
—
0
0
5
5
10.25
2.99
1.8
1.2
—
—
—
0
0
8
17
4.88
2.95
1.0
1.1
—
—
—
0
0
8
17
4.88
2.95
1.0
1.1
—
—
—
0
0
5
6
8.54
2.76
1.8
1.2
—
—
—
0
0
30
164
2.01
2.76
2.8
2.4
21.3
23.8
%
0.37
21
145
16
67
2.53
2.72
1.2
1.2
123.3
97.0
iu/ml
—
6
22
26
136
2.08
2.69
1.4
2.0
2.4
1.7
%
0.95
20
116
17
74
2.44
2.68
1.7
1.6
—
—
—
0
0
9
25
3.74
2.61
1.2
1.6
—
—
—
0
0
26
140
2.01
2.49
1.4
1.2
—
—
—
0
0
17
78
2.31
2.40
20.9
7.9
24.9
25.0
mmol/l
0.10
17
69
119
1352
0.60
2.32
4.2
5.0
1.5
1.4
mmol/l
0.60
113
1234
18
88
2.17
2.21
21.2
8.2
0.9
0.7
%
0.74
18
88
121
1363
0.60
2.15
4.3
5.0
4.5
4.5
mmol/l
0.05
115
1250
18
90
2.12
2.09
21.2
8.1
1.5
1.5
%
0.12
18
90
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
38
2.73
2.05
2.2
2.2
0.4
0.3
u/ml
—
5
21
8
26
3.18
2.04
1.5
1.3
—
—
—
0
0
125
1392
0.61
2.01
4.5
5.6
2.6
2.6
mmol/l
0.13
117
1271
15
71
2.22
1.99
14.1
7.5
26.5
25.5
mmol/l
0.32
15
71
41
274
1.66
1.97
3.8
4.1
43.0
511.1
ng/l
2.13
35
227
113
962
1.53
1.80
4.9
3.6
14.5
15.1
pmol/l
1.44
105
854
21
122
1.82
1.64
4.7
3.0
—
—
—
0
0
118
1308
0.68
1.47
6.0
6.8
39.4
41.1
mmol/mol
1.29
111
1207
10
47
2.20
1.36
1.6
1.5
—
—
—
0
0
47
359
1.43
1.21
3.1
2.7
0.6
0.4
e6/l
0.17
34
270
60
483
1.38
1.14
2.8
2.4
188.2
159.9
ug/l
0.51
55
438
30
212
1.50
1.14
3.1
2.8
2.1
1.8
e6/l
0.06
19
127
10
51
2.02
1.13
2.0
1.6
—
—
—
0
0
141
1314
1.44
0.97
30.1
12.8
34.1
23.5
mg/l
2.98
133
1018
9
51
1.81
0.96
1.3
1.3
—
—
—
0
0
40
312
1.37
0.91
1.5
1.5
24.2
19.4
nmol/l
0.70
34
267
34
260
1.39
0.87
2.1
1.7
1267.7
1246.0
nmol/l
0.05
26
205
30
228
1.38
0.80
3.1
2.6
0.5
1.1
e6/l
0.77
19
141
56
470
1.29
0.77
2.9
2.9
—
—
—
0
0
7
38
1.88
0.74
1.1
1.1
—
—
—
0
0
7
38
1.88
0.74
1.1
1.1
—
—
—
0
0
64
735
0.79
0.73
3.2
3.9
1.7
2.0
ug/l
1.00
57
655
5
26
1.95
0.71
1.2
1.1
—
—
—
0
0
49
577
0.79
0.69
2.7
3.6
18.9
24.3
%
1.62
18
266
42
499
0.79
0.63
5.1
3.7
—
—
—
0
0
34
414
0.78
0.62
2.1
2.6
0.8
0.8
ug/l
0.19
22
277
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
13
89
1.50
0.60
2.2
1.4
—
—
—
0
0
0
22
0.00
0.60
0.0
1.1
—
7.7
—
0
14
74
665
1.20
0.53
2.5
2.4
—
—
—
0
0
10
67
1.52
0.51
1.8
2.3
325.2
959.5
ug/l
—
10
62
105
980
1.19
0.47
3.5
3.9
19.6
11.5
mm/h
3.40
97
898
114
1075
1.19
0.44
36.8
15.1
14.4
13.6
%
4.61
114
1052
6
91
0.65
0.43
2.2
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
92
857
1.16
0.40
4.0
3.2
79.0
52.1
u/l
0.47
87
788
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
62
562
1.16
0.38
1.9
1.9
94.0
92.3
pmol/l
0.11
29
288
9
68
1.34
0.38
1.8
3.8
25.3
24.9
mmol/l
—
9
60
130
1350
0.84
0.38
3.6
5.0
6.1
6.2
mmol/l
0.15
122
1215
139
1435
0.82
0.38
34.6
15.3
75.7
82.6
umol/l
1.59
139
1435
6
41
1.48
0.36
1.3
1.1
—
—
—
0
0
125
1202
1.15
0.31
5.7
4.5
2.9
2.0
mu/l
2.80
118
1077
18
216
0.81
0.30
1.3
1.3
9.7
31.9
iu/ml
—
5
74
131
1268
1.15
0.27
26.6
11.7
82.8
76.7
ml/min/173m2
2.57
112
1022
17
202
0.82
0.26
1.2
1.2
47.0
8.9
u/ml
—
5
70
55
591
0.90
0.23
4.1
4.1
30.8
44.5
ng/l
0.80
48
438
11
88
1.27
0.23
2.9
2.2
1.9
1.2
%
0.75
11
88
5
39
1.29
0.23
2.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
1.2
—
0
8
33
301
1.12
0.18
1.5
1.8
616.4
22984289.0
pmol/l
0.50
28
248
61
637
0.93
0.13
4.5
3.5
0.0
0.0
estimate
—
9
92
59
616
0.94
0.12
4.6
3.5
0.0
0.0
estimate
—
10
92
40
377
1.08
0.12
3.6
2.3
345.6
9939.5
umol/l
2.26
34
329
120
1177
1.07
0.11
31.4
13.7
37.3
40.0
%
2.19
80
783
23
246
0.92
0.08
1.3
1.2
2.0
1.8
u/ml
—
8
64
19
176
1.09
0.08
8.8
7.2
—
—
—
0
0
61
628
0.96
0.07
6.1
4.9
0.0
0.0
estimate
—
9
95
32
326
0.98
0.00
4.8
3.6
0.0
0.0
estimate
—
9
90
6
64
0.94
0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.2
2.5
39.6
39.8
u/l
—
5
52
0
6
0.00
0.00
0.0
1.0
—
1294.5
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
10.2
—
0
8
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OROPHARYNG_EXALLC – Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).